{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:09:50Z","timestamp":1743221390473,"version":"3.40.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"DOI":"10.7759\/cureus.81341","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:44:52Z","timestamp":1743155092000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Intraocular Pressure Elevation After Commercially Available Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency"],"prefix":"10.7759","author":[{"given":"Hiroki","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Kimakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Toyono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9798374","article-title":"Limbal stem cell deficiency: current treatment options and emerging therapies","volume":"2016","author":"Haagdorens M","year":"2016","unstructured":"Haagdorens M, Van Acker SI, Van Gerwen V, N\u00ed Dhubhghaill S, Koppen C, Tassignon MJ, Zakaria N. Limbal stem cell deficiency: current treatment options and emerging therapies. Stem Cells Int. 2016, 2016:9798374. 10.1155\/2016\/9798374","journal-title":"Stem Cells Int"},{"key":"ref2","article-title":"Corneal re-epithelialization from the conjunctiva","volume":"21","author":"Shapiro MS","year":"1981","unstructured":"Shapiro MS, Friend J, Thoft RA. Corneal re-epithelialization from the conjunctiva. Invest Ophthalmol Vis Sci. 1981, 21:135-42.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)72167-1","article-title":"Ocular surface abnormalities in aniridia","volume":"120","author":"Nishida K","year":"1995","unstructured":"Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S. Ocular surface abnormalities in aniridia. Am J Ophthalmol. 1995, 120:368-75. 10.1016\/s0002-9394(14)72167-1","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2017.1353834","article-title":"Limbal stem cell transplantation and complications","volume":"33","author":"Yin J","year":"2018","unstructured":"Yin J, Jurkunas U. Limbal stem cell transplantation and complications. Semin Ophthalmol. 2018, 33:134-41. 10.1080\/08820538.2017.1353834","journal-title":"Semin Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.038497","article-title":"Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders","volume":"88","author":"Nakamura T","year":"2004","unstructured":"Nakamura T, Inatomi T, Sotozono C, Amemiya T, Kanamura N, Kinoshita S. Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol. 2004, 88:1280-4. 10.1136\/bjo.2003.038497","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.053","article-title":"Visual improvement after cultivated oral mucosal epithelial transplantation","volume":"120","author":"Sotozono C","year":"2013","unstructured":"Sotozono C, Inatomi T, Nakamura T, et al.. Visual improvement after cultivated oral mucosal epithelial transplantation. Ophthalmology. 2013, 120:193-200. 10.1016\/j.ophtha.2012.07.053","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12397","article-title":"Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity","volume":"92","author":"Sotozono C","year":"2014","unstructured":"Sotozono C, Inatomi T, Nakamura T, et al.. Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmol. 2014, 92:e447-53. 10.1111\/aos.12397","journal-title":"Acta Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10561-016-9575-4","article-title":"Long-term result of autologous cultivated oral mucosal epithelial transplantation for severe ocular surface disease","volume":"17","author":"Prabhasawat P","year":"2016","unstructured":"Prabhasawat P, Ekpo P, Uiprasertkul M, Chotikavanich S, Tesavibul N, Pornpanich K, Luemsamran P. Long-term result of autologous cultivated oral mucosal epithelial transplantation for severe ocular surface disease. Cell Tissue Bank. 2016, 17:491-503. 10.1007\/s10561-016-9575-4","journal-title":"Cell Tissue Bank"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2009.60","article-title":"Transplantation of cultivated oral mucosal epithelial cells for severe corneal burn","volume":"23","author":"Ma DH","year":"2009","unstructured":"Ma DH, Kuo MT, Tsai YJ, et al.. Transplantation of cultivated oral mucosal epithelial cells for severe corneal burn. Eye (Lond). 2009, 23:1442-50. 10.1038\/eye.2009.60","journal-title":"Eye (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31817f358e","article-title":"Recent advances in cultivated epithelial transplantation","volume":"27","author":"Higa K","year":"2008","unstructured":"Higa K, Shimazaki J. Recent advances in cultivated epithelial transplantation. Cornea. 2008, 27:S41-7. 10.1097\/ICO.0b013e31817f358e","journal-title":"Cornea"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-020-00797-2","article-title":"Evaluation of fornix-based trabeculectomy outcomes in Japanese glaucoma patients based on concrete long-term preoperative data","volume":"65","author":"Fujita A","year":"2021","unstructured":"Fujita A, Sakata R, Ueda K, et al.. Evaluation of fornix-based trabeculectomy outcomes in Japanese glaucoma patients based on concrete long-term preoperative data. Jpn J Ophthalmol. 2021, 65:306-12. 10.1007\/s10384-020-00797-2","journal-title":"Jpn J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108926","article-title":"Early clinical outcomes of the first commercialized human autologous ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: two case reports and literature review","volume":"24","author":"Toshida H","year":"2023","unstructured":"Toshida H, Kasahara T, Kiriyama M, et al.. Early clinical outcomes of the first commercialized human autologous ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: two case reports and literature review. Int J Mol Sci. 2023, 24:8926. 10.3390\/ijms24108926","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01783-8","article-title":"Ex vivo\u00a0cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: a review","volume":"11","author":"Cabral JV","year":"2020","unstructured":"Cabral JV, Jackson CJ, Utheim TP, Jirsova K. Ex vivo\u00a0cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: a review. Stem Cell Res Ther. 2020, 11:301. 10.1186\/s13287-020-01783-8","journal-title":"Stem Cell Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318547","article-title":"Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrising diseases","volume":"106","author":"Komai S","year":"2022","unstructured":"Komai S, Inatomi T, Nakamura T, et al.. Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrising diseases. Br J Ophthalmol. 2022, 106:1355-62. 10.1136\/bjophthalmol-2020-318547","journal-title":"Br J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-4835(05)80131-9","article-title":"Chronic ocular hypertension following episcleral venous occlusion in rats","volume":"61","author":"Shareef SR","year":"1995","unstructured":"Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res. 1995, 61:379-82. 10.1016\/s0014-4835(05)80131-9","journal-title":"Exp Eye Res"},{"key":"ref16","article-title":"Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats","volume":"43","author":"Levkovitch-Verbin H","year":"2002","unstructured":"Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002, 43:402-10.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2020.01.002","article-title":"Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management","volume":"65","author":"Roberti G","year":"2020","unstructured":"Roberti G, Oddone F, Agnifili L, et al.. Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol. 2020, 65:458-72. 10.1016\/j.survophthal.2020.01.002","journal-title":"Surv Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002211","article-title":"Comparison of 5-year clinical results of Descemet and non-Descemet stripping automated endothelial keratoplasty","volume":"39","author":"Omoto T","year":"2020","unstructured":"Omoto T, Toyono T, Inoue T, et al.. Comparison of 5-year clinical results of Descemet and non-Descemet stripping automated endothelial keratoplasty. Cornea. 2020, 39:573-7. 10.1097\/ICO.0000000000002211","journal-title":"Cornea"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2019.1597127","article-title":"Effects of anti-glaucoma prostaglandin ophthalmic solutions on cultured human corneal epithelial cells","volume":"44","author":"Tong L","year":"2019","unstructured":"Tong L, Matsuura E, Takahashi M, Nagano T, Kawazu K. Effects of anti-glaucoma prostaglandin ophthalmic solutions on cultured human corneal epithelial cells. Curr Eye Res. 2019, 44:856-62. 10.1080\/02713683.2019.1597127","journal-title":"Curr Eye Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2021.1902341","article-title":"Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study","volume":"40","author":"G\u00fc\u00e7l\u00fc H","year":"2021","unstructured":"G\u00fc\u00e7l\u00fc H, \u00c7\u0131nar AK, \u00c7\u0131nar AC, Akaray \u0130, \u015eambel Aykutlu M, Sakall\u0131o\u011flu AK, G\u00fcrl\u00fc V. Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study. Cutan Ocul Toxicol. 2021, 40:85-94. 10.1080\/15569527.2021.1902341","journal-title":"Cutan Ocul Toxicol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1097\/00061198-199812000-00007","article-title":"Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group","volume":"7","author":"Adamsons IA","year":"1998","unstructured":"Adamsons IA, Polis A, Ostrov CS, Boyle JE. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group. J Glaucoma. 1998, 7:395-401.","journal-title":"J Glaucoma"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2023.1067942","article-title":"Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy","volume":"5","author":"Ruiz-Lozano RE","year":"2023","unstructured":"Ruiz-Lozano RE, Azar NS, Mousa HM, et al.. Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy. Front Toxicol. 2023, 5:1067942. 10.3389\/ftox.2023.1067942","journal-title":"Front Toxicol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2008.0140","article-title":"Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells","volume":"25","author":"Epstein SP","year":"2009","unstructured":"Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009, 25:415-24. 10.1089\/jop.2008.0140","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001168","article-title":"Conjunctival goblet cells, the overlooked cells in glaucoma treatment","volume":"28","author":"Tiedemann D","year":"2019","unstructured":"Tiedemann D, Mouhammad ZA, Utheim TP, Dartt DA, Heegaard S, Petrovski G, Kolko M. Conjunctival goblet cells, the overlooked cells in glaucoma treatment. J Glaucoma. 2019, 28:325-33. 10.1097\/IJG.0000000000001168","journal-title":"J Glaucoma"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2019.02.002","article-title":"Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes","volume":"2","author":"Sarrafpour S","year":"2019","unstructured":"Sarrafpour S, Saleh D, Ayoub S, Radcliffe NM. Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma. 2019, 2:167-71. 10.1016\/j.ogla.2019.02.002","journal-title":"Ophthalmol Glaucoma"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2020.1810711","article-title":"A review of cyclodestructive procedures for the treatment of glaucoma","volume":"35","author":"Anand N","year":"2020","unstructured":"Anand N, Klug E, Nirappel A, Sol\u00e1-Del Valle D. A review of cyclodestructive procedures for the treatment of glaucoma. Semin Ophthalmol. 2020, 35:261-75. 10.1080\/08820538.2020.1810711","journal-title":"Semin Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001897","article-title":"Micropulse transscleral cyclophotocoagulation in keratoplasty eyes","volume":"38","author":"Subramaniam K","year":"2019","unstructured":"Subramaniam K, Price MO, Feng MT, Price FW Jr. Micropulse transscleral cyclophotocoagulation in keratoplasty eyes. Cornea. 2019, 38:542-5. 10.1097\/ICO.0000000000001897","journal-title":"Cornea"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328696-management-of-intraocular-pressure-elevation-after-commercially-available-cultivated-oral-mucosal-epithelial-cell-transplantation-for-limbal-stem-cell-deficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:44:56Z","timestamp":1743155096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328696-management-of-intraocular-pressure-elevation-after-commercially-available-cultivated-oral-mucosal-epithelial-cell-transplantation-for-limbal-stem-cell-deficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.81341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}